at Zacks.com (Fri, 2:00PM)
While Illumina (ILMN +3.9%) has rebounded from the weakness caused by Life Technologies' (LIFE...
While Illumina (ILMN +3.9%) has rebounded from the weakness caused by Life Technologies' (LIFE +7.2%) product announcement, smaller rival Complete Genomics' (GNOM -19.9%) bloodletting worsens as the day progresses. On Monday, the company announced it delivered 300 fewer genomes in Q4 than previously expected, news that triggered a downgrade from Oppenheimer.
From other sites
at Zacks.com (Fri, 8:46AM)
at Zacks.com (Thu, 5:50PM)
at Investor's Business Daily (Tue, 5:55PM)
at Zacks.com (Jan 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs